Announced
Synopsis
$90 million sale of Astute Medical, a pioneer of protein biomarker-derived diagnostic solutions, to bioMérieux, a publicly traded diagnostic company.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite